Literature DB >> 8785023

Glucocorticoids attenuate haloperidol-induced catalepsy through adrenal catecholamines.

C T Chopde1, M S Hote, S N Mandhane, A V Muthal.   

Abstract

To examine the influence of adrenal secretions on neuroleptic induced catalepsy, we studied the effect of adrenocorticoids, noradrenaline (NA) or adrenaline (AD) on haloperidol (HAL) induced catalepsy in adrenalectomised (ADX) and sham-adrenalectomised (sham-ADX) rats. HAL (1 mg/kg, i.p.) induced a greater degree of catalepsy in ADX rats as compared to sham-ADX rats. Corticosterone (CORT, 1-2 mg/kg, s.c.) or dexamethasone (1-2 mg/kg, s.c.) attenuated the HAL catalepsy in sham-ADX but not in ADX rats. Further, when the HAL (1 mg/kg) catalepsy score was maximal (at 120 min), the rats were subjected to cold stress (3 degrees C for 10 min) or treated with NA, AD (2 micrograms/kg, i.v.) or CORT (2 mg/kg, s.c.). After cold stress procedure or CORT treatment, the catalepsy was significantly reduced in sham-ADX but not in ADX rats, whereas NA or AD infusion caused an immediate but short lasting significant decrease in HAL catalepsy in both sham-ADX and ADX rats. The anticataleptic effect of NA or glucocorticoids was blocked by an alpha 1 adrenoceptor blocker, prazosin. These findings suggest that peripheral noradrenergic and adrenergic mechanisms play an important role in the neuroleptic induced catalepsy. Such mechanisms may mediate the anticataleptic action of glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8785023     DOI: 10.1007/bf01276564

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  15 in total

1.  CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.

Authors:  P Riederer; W D Rausch; W Birkmayer; K Jellinger; D Seemann
Journal:  J Neural Transm Suppl       Date:  1978

2.  Lack of glucocorticoids sustains the stress-induced release of noradrenaline in the anterior hypothalamus.

Authors:  G C Vetrugno; J Lachuer; C Perego; E Miranda; M G De Simoni; M Tappaz
Journal:  Neuroendocrinology       Date:  1993-05       Impact factor: 4.914

3.  The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  R S Burns; P A LeWitt; M H Ebert; H Pakkenberg; I J Kopin
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

4.  Modification of drug-induced catatonia and tremors by quapazine in rats and mice.

Authors:  S K Kulkarni; A Arzi; P N Kaul
Journal:  Jpn J Pharmacol       Date:  1980-04

Review 5.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

6.  Familial glucocorticoid deficiency with achalasia of the cardia associated with mixed neuropathy, long-tract degeneration and mild dementia.

Authors:  D B Grant; D B Dunger; I Smith; K Hyland
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

7.  Transient supression by stress of haloperidol induced catalepsy by the activation of the adrenal medulla.

Authors:  O P Yntema; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Akinesia in parkinsonism--clinical and pharmacological analysis of parkinsonian symptoms.

Authors:  H Narabayashi
Journal:  Bull Mem Acad R Med Belg       Date:  1984

Review 9.  Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.

Authors:  P Jenner; M Sheehy; C D Marsden
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

10.  [A case of progressive systemic sclerosis and Sjögren's syndrome complicated by parkinsonism with special reference to the beneficial effect of corticosteroid].

Authors:  T Nagao; K Takagi; H Hashida; T Masaki; M Sakuta
Journal:  Rinsho Shinkeigaku       Date:  1991-11
View more
  1 in total

1.  Correlation between cataleptic freezing and prepulse inhibition of the startle reflex in rats.

Authors:  N N Barykina; T A Alekhina; V F Chugui; O I Petrenko; N K Popova; V G Kolpakov
Journal:  Neurosci Behav Physiol       Date:  2004-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.